
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(R) | 2,495 | 99.8% | 0.26 | 2,986 | 99.7% |
| CentralBrain-unspecified | 5 | 0.2% | 1.00 | 10 | 0.3% |
| upstream partner | # | NT | conns TRN_VP3a | % In | CV |
|---|---|---|---|---|---|
| l2LN22 (R) | 2 | unc | 245.3 | 31.6% | 0.1 |
| TRN_VP3a | 3 | ACh | 186 | 23.9% | 0.0 |
| v2LN4 (L) | 3 | ACh | 125.3 | 16.1% | 0.1 |
| lLN2F_a (R) | 2 | unc | 53.7 | 6.9% | 0.1 |
| lLN2F_b (R) | 2 | GABA | 53.3 | 6.9% | 0.1 |
| GNG121 (L) | 1 | GABA | 25 | 3.2% | 0.0 |
| lLN2T_b (R) | 2 | ACh | 13.3 | 1.7% | 0.1 |
| lLN2R_a (R) | 2 | GABA | 13 | 1.7% | 0.9 |
| lLN2X04 (R) | 2 | ACh | 12 | 1.5% | 0.1 |
| TRN_VP3b | 1 | ACh | 10.3 | 1.3% | 0.0 |
| VP3+_l2PN (R) | 3 | ACh | 10 | 1.3% | 0.7 |
| lLN2X11 (R) | 2 | ACh | 6 | 0.8% | 0.2 |
| VP3+_l2PN (L) | 1 | ACh | 5.3 | 0.7% | 0.0 |
| lLN2X05 (R) | 2 | ACh | 4.7 | 0.6% | 0.1 |
| CB1048 (R) | 2 | Glu | 2.3 | 0.3% | 0.7 |
| v2LN32 (R) | 1 | Glu | 1.7 | 0.2% | 0.0 |
| v2LN49 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| il3LN6 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| v2LN34A (R) | 2 | Glu | 1 | 0.1% | 0.3 |
| lLN1_bc (R) | 3 | ACh | 1 | 0.1% | 0.0 |
| l2LN20 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| VP5+VP3_l2PN (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| lLN2X12 (R) | 2 | ACh | 0.7 | 0.1% | 0.0 |
| v2LN4 (R) | 1 | ACh | 0.7 | 0.1% | 0.0 |
| l2LN21 (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| M_l2PN10t19 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| lLN2P_b (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| PPM1201 (R) | 1 | DA | 0.3 | 0.0% | 0.0 |
| ORN_VC3 | 1 | ACh | 0.3 | 0.0% | 0.0 |
| TRN_VP2 | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ALIN8 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| lLN1_a (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns TRN_VP3a | % Out | CV |
|---|---|---|---|---|---|
| VP3+_l2PN (R) | 3 | ACh | 1,047.7 | 28.6% | 0.3 |
| l2LN22 (R) | 2 | unc | 435.3 | 11.9% | 0.0 |
| l2LN21 (R) | 1 | GABA | 335.3 | 9.2% | 0.0 |
| VP3+_l2PN (L) | 2 | ACh | 224 | 6.1% | 0.8 |
| VP5+VP3_l2PN (R) | 1 | ACh | 220 | 6.0% | 0.0 |
| TRN_VP3a | 3 | ACh | 186 | 5.1% | 0.2 |
| l2LN20 (R) | 2 | GABA | 184 | 5.0% | 0.1 |
| v2LN4 (R) | 3 | ACh | 151.3 | 4.1% | 0.1 |
| v2LN4 (L) | 3 | ACh | 98.3 | 2.7% | 0.2 |
| MZ_lv2PN (R) | 1 | GABA | 91 | 2.5% | 0.0 |
| lLN2T_b (R) | 2 | ACh | 89.7 | 2.4% | 0.2 |
| lLN2F_a (R) | 2 | unc | 76.3 | 2.1% | 0.0 |
| lLN2F_b (R) | 2 | GABA | 71 | 1.9% | 0.4 |
| DNb05 (R) | 1 | ACh | 68.3 | 1.9% | 0.0 |
| VP1l+VP3_ilPN (R) | 1 | ACh | 56.7 | 1.5% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 51 | 1.4% | 0.0 |
| lLN2X04 (R) | 2 | ACh | 36.3 | 1.0% | 0.1 |
| CB1048 (R) | 4 | Glu | 24.7 | 0.7% | 0.4 |
| M_l2PN10t19 (R) | 2 | ACh | 20.7 | 0.6% | 0.9 |
| lLN2X11 (R) | 2 | ACh | 20.3 | 0.6% | 0.5 |
| M_l2PN10t19 (L) | 1 | ACh | 19.7 | 0.5% | 0.0 |
| v2LN38 (L) | 2 | ACh | 16.3 | 0.4% | 0.6 |
| VP3+_vPN (R) | 1 | GABA | 11.3 | 0.3% | 0.0 |
| TRN_VP3b | 1 | ACh | 11 | 0.3% | 0.0 |
| v2LN33 (R) | 2 | ACh | 10 | 0.3% | 0.8 |
| VP3+VP1l_ivPN (R) | 1 | ACh | 9 | 0.2% | 0.0 |
| CB3417 (R) | 4 | unc | 8.3 | 0.2% | 0.7 |
| VP3+VP1l_ivPN (L) | 1 | ACh | 7.7 | 0.2% | 0.0 |
| lLN2R_a (R) | 2 | GABA | 7.7 | 0.2% | 0.9 |
| v2LN49 (R) | 2 | Glu | 7.7 | 0.2% | 0.4 |
| v2LN31 (R) | 1 | unc | 6 | 0.2% | 0.0 |
| AL-AST1 (R) | 1 | ACh | 6 | 0.2% | 0.0 |
| lLN2X05 (R) | 2 | ACh | 6 | 0.2% | 0.3 |
| M_l2PNm16 (R) | 2 | ACh | 6 | 0.2% | 0.4 |
| GNG121 (L) | 1 | GABA | 5.3 | 0.1% | 0.0 |
| VP5+Z_adPN (R) | 1 | ACh | 4.3 | 0.1% | 0.0 |
| M_l2PNm17 (R) | 1 | ACh | 3.7 | 0.1% | 0.0 |
| v2LN38 (R) | 1 | ACh | 3.3 | 0.1% | 0.0 |
| lLN1_a (R) | 1 | ACh | 2.7 | 0.1% | 0.0 |
| v2LN34A (R) | 3 | Glu | 2.7 | 0.1% | 0.2 |
| lLN2X12 (R) | 3 | ACh | 2.3 | 0.1% | 0.5 |
| lLN1_bc (R) | 3 | ACh | 2.3 | 0.1% | 0.4 |
| lLN2P_a (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| M_ilPNm90 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| lLN2T_a (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| M_smPNm1 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| ALIN2 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| vLN25 (R) | 2 | Glu | 1 | 0.0% | 0.3 |
| lLN2P_b (R) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| LHAD4a1 (R) | 1 | Glu | 0.7 | 0.0% | 0.0 |
| l2LN23 (R) | 1 | GABA | 0.7 | 0.0% | 0.0 |
| ORN_VC3 | 2 | ACh | 0.7 | 0.0% | 0.0 |
| aDT4 (R) | 1 | 5-HT | 0.3 | 0.0% | 0.0 |
| M_lvPNm48 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| v2LN33 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| lLN2P_c (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| ALON2 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| VP4+VL1_l2PN (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| VP1m+VP5_ilPN (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| M_VPNml66 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| VP1m+_lvPN (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| vLN29 (R) | 1 | unc | 0.3 | 0.0% | 0.0 |
| M_l2PN3t18 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| VES017 (R) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 0.3 | 0.0% | 0.0 |